SG43311A1 - Use of a tetrahydrocarbazolone derivative for the manufacture of medicaments - Google Patents

Use of a tetrahydrocarbazolone derivative for the manufacture of medicaments

Info

Publication number
SG43311A1
SG43311A1 SG1996008047A SG1996008047A SG43311A1 SG 43311 A1 SG43311 A1 SG 43311A1 SG 1996008047 A SG1996008047 A SG 1996008047A SG 1996008047 A SG1996008047 A SG 1996008047A SG 43311 A1 SG43311 A1 SG 43311A1
Authority
SG
Singapore
Prior art keywords
sub
sup
alkyl
cycloalkyl
phenyl
Prior art date
Application number
SG1996008047A
Other languages
English (en)
Inventor
David Cedric Humber
George Blanch Ewan
Ian Harold Coates
James Angus Bell
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40347948&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG43311(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SG43311A1 publication Critical patent/SG43311A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
SG1996008047A 1985-06-25 1986-06-24 Use of a tetrahydrocarbazolone derivative for the manufacture of medicaments SG43311A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858516083A GB8516083D0 (en) 1985-06-25 1985-06-25 Heterocyclic compounds
GB868628474A GB8628474D0 (en) 1985-06-25 1986-11-28 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SG43311A1 true SG43311A1 (en) 1997-10-17

Family

ID=40347948

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996008047A SG43311A1 (en) 1985-06-25 1986-06-24 Use of a tetrahydrocarbazolone derivative for the manufacture of medicaments

Country Status (22)

Country Link
US (2) US4753789A (forum.php)
EP (2) EP0431443A3 (forum.php)
JP (2) JPS6253920A (forum.php)
AT (2) ATE134510T1 (forum.php)
AU (2) AU609028B2 (forum.php)
BE (1) BE1002249A4 (forum.php)
CA (1) CA1296637C (forum.php)
CH (1) CH672068A5 (forum.php)
CY (1) CY2000A (forum.php)
DE (2) DE3650488T2 (forum.php)
DK (1) DK624687A (forum.php)
FR (1) FR2613934B1 (forum.php)
GB (3) GB8516083D0 (forum.php)
HK (1) HK82597A (forum.php)
IE (1) IE60908B1 (forum.php)
IL (1) IL84638A (forum.php)
IT (1) IT1211937B (forum.php)
NL (1) NL8702853A (forum.php)
NZ (1) NZ222743A (forum.php)
SE (1) SE8704747L (forum.php)
SG (1) SG43311A1 (forum.php)
ZA (1) ZA878927B (forum.php)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE385517T1 (de) * 1985-03-14 1991-07-25 Beecham Group p.l.c., Brentford, Middlesex Arzneimittel zur behandlung von erbrechen.
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
US5578628A (en) * 1985-06-25 1996-11-26 Glaxo Group Limited Medicaments for the treatment of nausea and vomiting
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
GB8630080D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
GB8630079D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
IE60991B1 (en) * 1986-12-17 1994-09-07 Glaxo Group Ltd Use of ketone derivatives in the treatment of cognitive disorders
JPH0754759B2 (ja) * 1987-04-27 1995-06-07 日本電信電話株式会社 プラズマ処理方法および装置並びにプラズマ処理装置用モード変換器
US4943428A (en) * 1987-07-10 1990-07-24 Wright State University Stimulation of serotonin-1A receptors in mammals to alleviate motion sickness and emesis induced by chemical agents
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
GB8806224D0 (en) * 1988-03-16 1988-04-13 Johnson Matthey Plc Platinum chemotherapeutic product
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
AU627221B2 (en) * 1988-09-27 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Pyridoindole derivatives and processes for preparation thereof
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
US5039528A (en) * 1989-12-11 1991-08-13 Olney John W EAA antagonists as anti-emetic drugs
US4971651A (en) * 1990-02-05 1990-11-20 Hitachi, Ltd. Microwave plasma processing method and apparatus
WO1993000075A1 (en) * 1991-06-26 1993-01-07 Sepracor, Inc. Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron
EP1022025A3 (en) * 1991-06-26 2002-06-05 Sepracor, Inc. Method and compositions for treating emesis nausea and other disorders using optically pure R(+) ondansetron
ATE195867T1 (de) * 1991-09-20 2000-09-15 Glaxo Group Ltd Neue medizinische indikation für tachykinin- antagonisten
HUT68293A (en) * 1993-03-08 1995-06-28 Fujisawa Pharmaceutical Co 5-ht antagonists as acting agent against cerebrovascular deseases
GB9310756D0 (en) * 1993-05-25 1993-07-14 Glaxo Lab Sa Compositions
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
WO2000051582A2 (en) 1999-03-01 2000-09-08 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
RU2162695C1 (ru) * 2000-07-14 2001-02-10 ООО с иностранными инвестициями "Редди-Биомед лимитед" Способ получения ондансетрона гидрохлорида дигидрата, субстанция и фармацевтический препарат
KR100434390B1 (ko) * 2001-04-20 2004-06-04 안국약품 주식회사 1,2,3,9-테트라히드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카바졸-4-온을 유효성분으로 하는 비강분무용조성물
JP5690461B2 (ja) * 2002-11-15 2015-03-25 ヘルシン ヘルスケア ソシエテ アノニム 化学療法誘導嘔吐を治療するためのパロノセトロン
MXPA05007379A (es) * 2003-01-13 2006-02-10 Dynogen Pharmaceuticals Inc Metodo para tratar nauseas, vomito, esfuerzo por vomitar o cualquier combinacion de los mismos.
JO2735B1 (en) 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
TWI355936B (en) 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US20060167072A1 (en) * 2004-01-30 2006-07-27 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
WO2005108392A2 (en) * 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
US20060068010A1 (en) * 2004-09-30 2006-03-30 Stephen Turner Method for improving the bioavailability of orally delivered therapeutics
WO2006105117A2 (en) * 2005-03-28 2006-10-05 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
PL1940366T3 (pl) * 2006-10-24 2009-09-30 Helsinn Healthcare Sa Miękkie, zawierające chlorowodorek palonosetronu kapsułki o zwiększonej stabilności i biodostępności
JP2010050046A (ja) 2008-08-25 2010-03-04 Hitachi High-Technologies Corp プラズマ処理装置
EP2519226A1 (en) 2009-12-28 2012-11-07 MonoSol Rx, LLC Orally administrable film dosage forms containing ondansetron
MX342993B (es) 2013-04-25 2016-10-13 Inst Mexicano Del Petróleo Proceso de obtencion de copolimeros aleatorios derivados del acido itaconico y/o sus isomeros y alquenil sulfonatos de sodio y uso del producto obtenido.
US20200054611A1 (en) 2017-01-09 2020-02-20 Gt Biopharma, Inc. Use and composition for treating myasthenia gravis and other myasthenic syndromes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040489A1 (en) * 1980-05-17 1981-11-25 FISONS plc Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine
BE894285A (fr) * 1981-09-04 1983-03-02 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire et de la ranitidine ou un sel de ce compose
DE3445377A1 (de) * 1983-12-23 1985-07-04 Sandoz-Patent-GmbH, 7850 Lörrach Carbocylische und heterocyclische carbonsaeureester und -amide von ueberbrueckten und nicht ueberbrueckten cyclischen stickstoffhaltigen aminen oder alkoholen
DE3502508A1 (de) * 1984-01-25 1985-08-14 Glaxo Group Ltd., London Heterocyclische verbindungen
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
EP0191562B1 (en) * 1985-01-23 1991-07-10 Glaxo Group Limited Tetrahydrocarbazolone derivatives
DE385517T1 (de) * 1985-03-14 1991-07-25 Beecham Group p.l.c., Brentford, Middlesex Arzneimittel zur behandlung von erbrechen.
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8630079D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
CA1296637C (en) 1992-03-03
IE60908B1 (en) 1994-08-24
US4753789A (en) 1988-06-28
IE873230L (en) 1988-05-28
JPH0324447B2 (forum.php) 1991-04-03
AU6703786A (en) 1988-06-30
GB8628474D0 (en) 1987-01-07
ATA312587A (de) 1992-05-15
ATE134510T1 (de) 1996-03-15
IT1211937B (it) 1989-11-08
NZ222743A (en) 1991-09-25
SE8704747D0 (sv) 1987-11-27
AU8191487A (en) 1988-06-02
DE3740351A1 (de) 1988-06-09
AU616386B2 (en) 1991-10-31
BE1002249A4 (fr) 1990-11-06
HK82597A (en) 1997-06-27
DK624687A (da) 1988-05-29
DE3650488T2 (de) 1996-09-05
AT395374B (de) 1992-12-10
SE8704747L (sv) 1988-05-29
CY2000A (en) 1997-12-05
US4929632A (en) 1990-05-29
FR2613934A1 (fr) 1988-10-21
GB2200046B (en) 1990-09-26
EP0226266A3 (en) 1990-01-24
GB8727836D0 (en) 1987-12-31
ZA878927B (en) 1988-10-26
NL8702853A (nl) 1988-06-16
AU609028B2 (en) 1991-04-26
JPS63198623A (ja) 1988-08-17
DK624687D0 (da) 1987-11-27
JPS6253920A (ja) 1987-03-09
EP0226266A2 (en) 1987-06-24
GB8516083D0 (en) 1985-07-31
GB2200046A (en) 1988-07-27
IT8748643A0 (it) 1987-11-27
EP0431443A3 (en) 1991-09-18
IL84638A (en) 1992-05-25
CH672068A5 (forum.php) 1989-10-31
EP0226266B1 (en) 1996-02-28
EP0431443A2 (en) 1991-06-12
FR2613934B1 (fr) 1993-07-09
DE3650488D1 (de) 1996-04-04

Similar Documents

Publication Publication Date Title
SG43311A1 (en) Use of a tetrahydrocarbazolone derivative for the manufacture of medicaments
ES8105292A1 (es) Procedimiento para la obtencion de derivado de la difenilu- rea halogenosustituidos
NZ211906A (en) Phenol derivatives having antioestrogenic activity and pharmaceutical compositions
GB8826595D0 (en) Active compounds
EP0210753A3 (en) Anti-tumor medicament
NZ227082A (en) N-(23-vinblastinoyl) derivatives of 1-aminomethyl-phosphonic acid; process for their preparation; and pharmaceutical compositions containing them
IL70253A (en) N-nitrosourea phosphoric acid derivatives,their preparation and pharmaceutical compositions containing them
IL70797A (en) Triazole derivatives,their preparation and pharmaceutical and agricultural compositions containing them
MX9705737A (es) Indanilidinacetilguanidinas sustituidas, procedimiento para su preparacion, su uso como medicamentos o agentes de diagnostico y medicamentos que las contienen.
MY103293A (en) N-imidazolyl derivatives of bicyclic compounds useful in medicine
SE8603589D0 (sv) Metylendioxifenantren- och stilbenderivat
GB2152508A (en) Pyrimidine derivatives
GR861348B (en) New drug
EP0240986A3 (en) D-nor-7-ergoline derivatives, process for preparing them, pharmaceutical composition and use
AU1675692A (en) Medicaments containing azacyclodiphosphonic acid derivatives, novel azacyclodiphosphonic acid derivatives and process for producing them
KR890014116A (ko) 고혈압치료 혼합물
ES8504816A1 (es) Un procedimiento de preparacion de un derivado de cefalosporina
ES8504701A1 (es) Procedimiento para preparar derivados de 3-aril-3-pirrolina